Renaissance Technologies - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$683
-52.0%
474,080
-17.1%
0.00%
-50.0%
Q2 2023$1,424
+20.0%
571,791
+29.1%
0.00%0.0%
Q1 2023$1,187
-66.2%
442,975
-31.5%
0.00%
-60.0%
Q4 2022$3,514
-99.7%
647,100
+531.9%
0.01%
+150.0%
Q3 2022$1,279,000
-44.2%
102,400
-77.9%
0.00%
-33.3%
Q2 2022$2,292,000
-10.2%
464,000
+337.3%
0.00%0.0%
Q1 2021$2,553,000
+117.5%
106,100
+50.1%
0.00%
+200.0%
Q1 2019$1,174,000
+97.0%
70,700
+520.2%
0.00%0.0%
Q3 2018$596,000
-49.7%
11,400
-64.4%
0.00%0.0%
Q2 2018$1,186,0000.0%32,0000.0%0.00%0.0%
Q1 2018$1,186,00032,0000.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Birchview Capital, LP 120,000$172,8000.15%
DENALI ADVISORS LLC 148,800$214,2720.08%
XTX Topco Ltd 296,601$427,1050.07%
NEEDHAM INVESTMENT MANAGEMENT LLC 234,000$336,9600.06%
LEVEL FOUR ADVISORY SERVICES, LLC 183,400$264,0960.02%
Curi Wealth Management, LLC 70,742$101,8690.02%
FRANKLIN STREET ADVISORS INC /NC 83,400$1200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 140,000$201,6000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 573,256$825,4890.01%
ALGERT GLOBAL LLC 68,100$980.01%
View complete list of G1 THERAPEUTICS INC shareholders